Scalper1 News
Several highly rated tech companies and drugmakers are set to report earnings on Wednesday. Here’s a look at what analysts expect. Actavis (ACT) reports its results before the open. The specialty-drug giant is projected to earn $3.10 a share, a 48% jump from last year. Revenue is seen skyrocketing 80% to $3.63 billion. Botox maker Allergan (AGN), which is fighting off a hostile takeover bid from Valeant (VRX), confirmed Monday that it had been Scalper1 News
Scalper1 News